RESECTABLE NON-SMALL CELL LUNG CANCER
Clinical trials for RESECTABLE NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RESECTABLE NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost lung cancer surgery success
Disease control OngoingThis study tests whether adding an experimental drug (fianlimab) to standard immunotherapy (cemiplimab) and chemotherapy works better than the standard combination alone for people with early-stage lung cancer that can be removed by surgery. About 195 participants will receive tr…
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:59 UTC
-
New antib combo shows promise in lung cancer fight
Disease control OngoingThis study tests a new drug called AK112, given alone or with chemotherapy, before and after surgery for people with early-stage non-small cell lung cancer that can be removed. The goal is to see if it helps shrink tumors before surgery and prevent cancer from coming back after. …
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated May 26, 2026 09:52 UTC
-
Promising lung cancer combo trial pulled before it began
Disease control TerminatedThis study was designed to test whether giving a KRAS G12C-targeted drug (adagrasib) alone or with an immunotherapy (nivolumab) before surgery could improve outcomes for people with a specific type of non-small cell lung cancer. It was planned for adults with resectable tumors an…
Matched conditions: RESECTABLE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 22, 2026 14:03 UTC